These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 24501342)
1. Evaluation of the Borrelia burgdorferi BBA64 protein as a protective immunogen in mice. Brandt KS; Patton TG; Allard AS; Caimano MJ; Radolf JD; Gilmore RD Clin Vaccine Immunol; 2014 Apr; 21(4):526-33. PubMed ID: 24501342 [TBL] [Abstract][Full Text] [Related]
2. Tick-Tattoo: DNA Vaccination Against Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW Front Immunol; 2021; 12():615011. PubMed ID: 33717102 [TBL] [Abstract][Full Text] [Related]
3. Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease. Hassan WS; Giaretta PR; Rech R; Ollivault-Shiflett M; Esteve-Gasent MD Vaccine; 2019 Sep; 37(37):5596-5606. PubMed ID: 31387750 [TBL] [Abstract][Full Text] [Related]
4. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. Gilmore RD; Kappel KJ; Dolan MC; Burkot TR; Johnson BJ Infect Immun; 1996 Jun; 64(6):2234-9. PubMed ID: 8675332 [TBL] [Abstract][Full Text] [Related]
5. Multicomponent Lyme vaccine: three is not a crowd. Brown EL; Kim JH; Reisenbichler ES; Höök M Vaccine; 2005 May; 23(28):3687-96. PubMed ID: 15882529 [TBL] [Abstract][Full Text] [Related]
6. Investigating BB0405 as a novel Borrelia afzelii vaccination candidate in Lyme borreliosis. Klouwens MJ; Trentelman JJ; Ersoz JI; Nieves Marques Porto F; Sima R; Hajdusek O; Thakur M; Pal U; Hovius JW Sci Rep; 2021 Feb; 11(1):4775. PubMed ID: 33637813 [TBL] [Abstract][Full Text] [Related]
7. Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine. Straubinger RK; Dharma Rao T; Davidson E; Summers BA; Jacobson RH; Frey AB Vaccine; 2001 Oct; 20(1-2):181-93. PubMed ID: 11567763 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice. Ullmann AJ; Russell TM; Dolan MC; Williams M; Hojgaard A; Weiner ZP; Johnson BJ PLoS One; 2015; 10(6):e0128868. PubMed ID: 26076465 [TBL] [Abstract][Full Text] [Related]
9. Immunization of mice with Borrelia burgdorferi lp54 gene encoded recombinant proteins does not provide protection against tick transmitted infectious challenge. Brandt KS; Gilmore RD Vaccine; 2017 Sep; 35(40):5310-5313. PubMed ID: 28867507 [TBL] [Abstract][Full Text] [Related]
10. Structure of an outer surface lipoprotein BBA64 from the Lyme disease agent Borrelia burgdorferi which is critical to ensure infection after a tick bite. Brangulis K; Tars K; Petrovskis I; Kazaks A; Ranka R; Baumanis V Acta Crystallogr D Biol Crystallogr; 2013 Jun; 69(Pt 6):1099-107. PubMed ID: 23695254 [TBL] [Abstract][Full Text] [Related]
11. Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C. Edmondson DG; Prabhakaran S; Norris SJ; Ullmann AJ; Piesman J; Dolan M; Probst C; Radzimski C; Stöcker W; Komorowski L Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27733423 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of the Borrelia burgdorferi bba64 gene product in murine infection via tick infestation. Patton TG; Dietrich G; Dolan MC; Piesman J; Carroll JA; Gilmore RD PLoS One; 2011 May; 6(5):e19536. PubMed ID: 21559293 [TBL] [Abstract][Full Text] [Related]
13. Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine. Kumar M; Kaur S; Kariu T; Yang X; Bossis I; Anderson JF; Pal U Vaccine; 2011 Nov; 29(48):9012-9. PubMed ID: 21945261 [TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs. Scheckelhoff MR; Telford SR; Hu LT Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863 [TBL] [Abstract][Full Text] [Related]
15. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies. Kurtenbach K; Dizij A; Voet P; Hauser P; Simon MM Vaccine; 1997 Oct; 15(15):1670-4. PubMed ID: 9364698 [TBL] [Abstract][Full Text] [Related]
16. Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies. Ulbrandt ND; Cassatt DR; Patel NK; Roberts WC; Bachy CM; Fazenbaker CA; Hanson MS Infect Immun; 2001 Aug; 69(8):4799-807. PubMed ID: 11447153 [TBL] [Abstract][Full Text] [Related]
17. Live Attenuated Borrelia burgdorferi Targeted Mutants in an Infectious Strain Background Protect Mice from Challenge Infection. Hahn BL; Padmore LJ; Ristow LC; Curtis MW; Coburn J Clin Vaccine Immunol; 2016 Aug; 23(8):725-31. PubMed ID: 27335385 [TBL] [Abstract][Full Text] [Related]
18. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters. Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885 [TBL] [Abstract][Full Text] [Related]
19. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Fikrig E; Barthold SW; Kantor FS; Flavell RA Science; 1990 Oct; 250(4980):553-6. PubMed ID: 2237407 [TBL] [Abstract][Full Text] [Related]
20. Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes. Batool M; Caoili SEC; Dangott LJ; Gerasimov E; Ionov Y; Piontkivska H; Zelikovsky A; Waghela SD; Rogovskyy AS Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]